Mitrix Bio says anti-aging therapy already in early trials with 70-92 year olds
acmoytoy · x · 2026-10-31
Mitrix Bio (@PathfinderEq) says preliminary human safety trials for its anti-aging therapy were completed last month, and early trials now include participants aged 70-92. The quoted post estimates it will take at least 30 years before medicines allow everyone to live healthily to 120, and whether humanity can cross that lifespan limit remains unclear.
More from Research
- GOFish: fisheye-trained 3D Gaussian Splatting surpasses 180° FoV and extracts collision-ready meshes — janusch_patas · 2026-10-31
- Artifact Distillation: training-free transfer lets Claude Haiku 4.5 beat Sonnet 4.5 at 60% cost — kalyan_kpl · 2026-10-31
- AI researcher argues 90% of research is too vague to be wrong as automated review costs drop to zero — RexDouglass · 2026-10-31
- eSpinor: Anima Anandkumar's team proposes SU(2)-equivariant GNN for magnetic properties — AnimaAnandkumar · 2026-10-31
- Microsoft's ScholarEvolve evolves agent harnesses with frozen models, +14 points on AppWorld — jiqizhixin · 2026-10-31
- Exponential Residual Flows: an ODE sampler for discrete diffusion models — _onionesque · 2026-10-31